Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
1,174
-263
-18% -$74.3K 0.01% 446
2026
Q1
$383K Buy
1,437
+366
+34% +$101K 0.02% 400
2025
Q4
$295K Sell
1,071
-3,069
-74% -$860K 0.01% 443
2025
Q3
$1.19M Buy
4,140
+1,211
+41% +$358K 0.07% 213
2025
Q2
$968K Sell
2,929
-509
-15% -$164K 0.09% 192
2025
Q1
$1.13M Buy
+3,438
New +$1.04M 0.07% 246
2024
Q4
Sell
-619
Closed -$215K 553
2024
Q3
$215K Sell
619
-62
-9% -$21.3K 0.01% 519
2024
Q2
$225K Buy
681
+124
+22% +$42.8K 0.02% 477
2024
Q1
$202K Sell
557
-125
-18% -$41.1K 0.02% 493
2023
Q4
$204K Buy
+682
New +$199K 0.02% 483
2020
Q3
Sell
-337
Closed -$63K 352
2020
Q2
$63K Buy
337
+66
+24% +$12.5K 0.03% 346
2020
Q1
$48K Buy
271
+102
+60% +$19.8K 0.03% 342
2019
Q4
$35K Buy
+169
New +$31K 0.02% 398

Other funds holding CI

Procyon Advisors's CI Position: Q2 2026 in Review

Procyon Advisors reduced its Cigna (CI) stake by 18% in Q2 2026, selling an estimated $74.3K and leaving 1,174 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #446.

Procyon Advisors first reported a position in CI in Q4 2019 and has held it in 13 quarters since. The position peaked at $1.19M in Q3 2025. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Procyon Advisors held 1,174 shares of Cigna worth $324K as of Q2 2026.
  • Procyon Advisors sold 263 Cigna shares in Q2 2026, an estimated $74.3K.
  • Cigna made up 0.01% of Procyon Advisors's portfolio in Q2 2026, its #446 holding.
  • Procyon Advisors first reported a position in Cigna in Q4 2019 and has held it in 13 quarters since.
  • Procyon Advisors's Cigna position peaked at $1.19M in Q3 2025.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.